Mucosal irritation testing is a core component of the biological evaluation of medical devices required by ISO 10993-23 and the corresponding GB/T 16886 series, verifying that devices and materials that contact mucous membranes do not provoke unacceptable local tissue reactions. This technical article explains the applicable standards, sample and extract preparation, in vivo and in vitro test methods, scoring and interpretation criteria, and typical applications in regulatory submission and product development.
Technical Overview
Mucosal irritation testing evaluates whether a medical device, its material components, or their extractable substances induce a reversible or irreversible inflammatory response on mucosal surfaces such as the vaginal, oral, rectal, nasal, or ocular mucosa. It forms part of the biological evaluation framework defined by ISO 10993-1, which assigns required biological endpoints according to the nature, duration, and route of tissue contact.
The governing standard for this endpoint is ISO 10993-23:2021, Biological evaluation of medical devices — Part 23: Tests for irritation, which consolidated and replaced the irritation test content formerly located in ISO 10993-10. In China, the corresponding national standard is the GB/T 16886.23 adoption of the ISO 10993-23 methodology, and evaluation plans are structured per GB/T 16886.1. Typical observed endpoints include erythema, edema, discharge, epithelial erosion, and ulceration, assessed both macroscopically and through histopathological examination of excised tissue.
Modern practice follows a step-wise, 3Rs-compliant strategy consistent with ISO 10993-2 (animal welfare requirements): existing data, chemical characterization, cytotoxicity screening, and validated in vitro methods are considered first, and in vivo animal studies are performed only when scientifically justified within a documented biological evaluation plan.
Testing Samples
Medical Devices with Mucosal Contact
Typical products submitted to accredited third-party laboratories for mucosal irritation evaluation include:
- Urinary catheters, nasogastric tubes, and enteral feeding tubes
- Condoms, contraceptive diaphragms, intrauterine devices, vaginal rings, pessaries, and tampons
- Dentures, orthodontic appliances, mouthguards, dental impression materials, and other intraoral devices
- Nasal spray and inhalation drug delivery components, endotracheal tubes, and respiratory interfaces
- Ophthalmic devices and contact lens accessories contacting ocular mucosa
- Rectal and endoscopic devices, suppository applicators, lubricants, gels, and coatings
- Raw materials such as silicone elastomers, natural rubber latex, thermoplastic polymers, hydrogels, adhesives, and colorants
Sample Forms and Preparation
Test articles may be evaluated by direct mucosal contact or, more commonly, as extracts prepared in accordance with ISO 10993-12. Key preparation parameters include:
- Extraction media: a polar medium (physiological saline) and a non-polar medium (a vegetable oil such as cottonseed or sesame oil), with additional solvents selected on a justified case-by-case basis
- Extraction ratios: surface-area-based ratios of 3 cm²/mL or 6 cm²/mL depending on material thickness, or mass-based ratios of 0.1–0.2 g/mL for irregularly shaped solids; lumen-filling volumes apply to tubular devices
- Extraction conditions: 37°C for 72 hours as the physiological condition, or accelerated conditions such as 50°C for 72 hours, 70°C for 24 hours, or 121°C for 1 hour, selected so that the material is not degraded or altered
- Sample state: the final product in its clinically representative form, including the intended sterilization method, cleaning procedure, and packaging configuration
Testing Items
The core test item is site-specific mucosal irritation, comprising:
- Vaginal mucosal irritation (the most commonly performed in vivo model)
- Oral mucosal irritation for intraoral and oropharyngeal devices
- Rectal mucosal irritation for rectal delivery and examination devices
- Ocular irritation for devices and products contacting the eye
- Nasal and respiratory tract irritation, where justified by the clinical route of exposure
Evaluated endpoints include macroscopic irritation scores for erythema, edema, and discharge; histopathological grading of epithelial integrity, leukocyte infiltration, vascular congestion, edema, and ulceration; and the calculated irritation index compared against negative and positive controls. Mucosal irritation is frequently evaluated together with related endpoints such as intracutaneous reactivity, skin irritation, and sensitization as part of the overall biological evaluation panel.
Testing Methods
In Vivo Mucosal Irritation Test
The classical in vivo approach uses healthy adult nulliparous female rabbits, typically of the New Zealand White strain. A defined volume of extract or the test article itself is introduced into the vaginal canal for a specified exposure period, commonly one hour, with exposure repeated over consecutive days when the intended clinical contact is prolonged or repeated. After each exposure, the mucosa is macroscopically graded using the standardized 0–4 scales for erythema, edema, and discharge defined in ISO 10993-23 and GB/T 16886.23. At the scheduled end of the observation period, animals are humanely euthanized and the mucosal tissues are excised, fixed, sectioned, and examined by a veterinary pathologist.
Control Design
- Negative control: extraction vehicle alone or a sham procedure to establish baseline responses
- Positive control: a known irritant, such as a sodium dodecyl sulfate solution, to confirm the sensitivity of the test system
- Benchmark control: an equivalent clinically accepted material, where available, to support comparative interpretation
In Vitro Alternative Methods
In line with the in vitro-first philosophy of ISO 10993-23, several alternative methods are available for screening and, where regulatory frameworks accept them, for definitive evaluation:
- Hen's egg test on the chorioallantoic membrane (HET-CAM), which detects irritant-induced vascular and coagulative responses on the CAM
- Bovine corneal opacity and permeability testing for ocular irritation endpoints
- Reconstructed human epithelium models, including cornea-like and vaginal epithelium constructs, which quantify tissue viability after topical exposure
- Cytotoxicity testing per ISO 10993-5 as supporting evidence within a weight-of-evidence assessment
Scoring, Calculation, and Interpretation
- Macroscopic scoring: erythema, edema, and discharge graded from 0 (no reaction) to 4 (severe reaction)
- Irritation index: the summed scores divided by the number of scoring observations, yielding a mean primary irritation index
- Interpretation bands: approximately 0–0.4 negligible, 0.5–1.9 slight, 2.0–4.9 moderate, and 5.0–8.0 severe irritation
- Final conclusion: histopathological findings are correlated with macroscopic scores, and the test article is considered non-irritant when no biologically or statistically significant increase over the negative control is observed
Applications
Mucosal irritation testing data are used across the full product lifecycle:
- Regulatory registration submissions in China under NMPA requirements, in the United States under FDA expectations aligned with ISO 10993-1, and in the European Union under the MDR technical documentation framework
- Biological safety evaluation reports supporting risk management activities under ISO 10993-1 and ISO 14971
- Material selection, formulation optimization, and lubricant or coating screening during research and development
- Change control assessment when suppliers, manufacturing processes, sterilization methods, or packaging configurations are modified
- Safety substantiation for drug-device combination products and novel devices with direct or prolonged mucosal contact
FAQ
Question: When is mucosal irritation testing required for a medical device?
Answer: Testing is indicated when the device, or a component contacting it, touches mucous membranes during clinical use. The requirement is determined from the ISO 10993-1 and GB/T 16886.1 evaluation matrix based on contact nature (surface, external communication, or implant) and contact duration (limited, prolonged, or long-term). Existing data or chemical characterization may justify omitting the test, provided the rationale is documented in the biological evaluation plan.
Question: Can in vitro methods replace animal testing?
Answer: ISO 10993-23:2021 explicitly promotes an in vitro-first strategy. Validated in vitro methods such as reconstructed human epithelium models and HET-CAM can serve as screening tools or, where scientifically justified and regulatorily accepted, as replacements. In vivo studies remain necessary when in vitro results are inconclusive or when the route and duration of exposure are not adequately modeled in vitro.
Question: How much sample is needed for testing?
Answer: Sample quantity is calculated from the extraction ratios in ISO 10993-12. As a practical guide, sufficient material must be provided for both polar and non-polar extraction plus retention samples, with the test article representative of the final sterilized product.
Question: How long does mucosal irritation testing take?
Answer: A typical in vivo study requires approximately four to eight weeks, encompassing extract preparation, animal dosing and observation, histopathological processing, and report issuance. In vitro studies are generally shorter.
Question: What constitutes a passing result?
Answer: A device is considered non-irritant to mucosa when macroscopic scores, calculated irritation index, and histopathological findings show no significant difference from the negative control, and the positive control confirms test system sensitivity.
Question: How does mucosal irritation testing relate to intracutaneous reactivity testing?
Answer: Both tests are covered under ISO 10993-23, but they evaluate different exposure scenarios. Intracutaneous reactivity is a screening-level assessment of extract injections and does not substitute for route-specific mucosal evaluation when a device directly contacts mucosal tissue for prolonged or repeated periods.